Peter End
Impact in
- Immunology and Allergy top 2%
- Cell Adhesion Molecules Research
- Pharmacology top 1%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Protein Kinase Regulation and GTPase Signaling 5
- PI3K/AKT/mTOR signaling in cancer 3
-
- Cellular transport and secretion 3
- Co-authors
- George Panayotou (8 shared papers)Michael D. Waterfield (6 shared papers)Jürgen ENGEL (1 shared paper)Rupert Timpl (1 shared paper)Monique Aumailley (1 shared paper)Gerd A. Kullak‐Ublick (1 shared paper)Raúl J. Andrade (1 shared paper)Alexander L. Gerbes (1 shared paper)
- Journals
- Molecular and Cellular Biology (3 papers)Clinical and Translational Science (2 papers)Drug Metabolism and Disposition (2 papers)Current Biology (1 paper)Cell (1 paper)
- Partner nations
- SwitzerlandUnited StatesUnited Kingdom
In The Last Decade
Peter End
22 papers receiving 1.8k citations
Peter End's Hit Papers
Peers
Comparison fields: 5 of 112
- Immunology and Allergy 228
- Pharmacology 289
- Nephrology 176
- Cell Biology 241
- Hepatology 85
Countries citing papers authored by Peter End
This map shows the geographic impact of Peter End's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter End with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter End more than expected).
Fields of papers citing papers by Peter End
This network shows the impact of papers produced by Peter End. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter End. The network helps show where Peter End may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter End, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Drug-induced liver injury: recent advances in diagnosis and risk assessment Hit paper breakdown → | 2017 | 353 |
| 2 | 1989 | 279 | |
| 3 | 2010 | 263 | |
| 4 | 1992 | 181 | |
| 5 | 1993 | 136 | |
| 6 | 2013 | 131 | |
| 7 | 2007 | 104 | |
| 8 | 1992 | 78 | |
| 9 | 2021 | 71 | |
| 10 | 2021 | 62 | |
| 11 | 1993 | 47 | |
| 12 | 1993 | 31 | |
| 13 | 1993 | 27 | |
| 14 | 2020 | 23 | |
| 15 | 2015 | 18 | |
| 16 | 2017 | 16 | |
| 17 | 1993 | 15 | |
| 18 | 2019 | 8 | |
| 19 | 2021 | 7 | |
| 20 | 2022 | 6 |
About Peter End
Peter End is a scholar working on Molecular Biology, Cell Biology, Immunology, Pharmacology and Hematology, having authored 23 papers that have together received 1.9k indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (5 papers), Pharmacogenetics and Drug Metabolism (4 papers), Cellular transport and secretion (3 papers), Complement system in diseases (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Immunology and Allergy (228 citations), Pharmacology (289 citations), Nephrology (176 citations), Cell Biology (241 citations) and Hepatology (85 citations). Peter End has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include George Panayotou, Michael D. Waterfield, Jürgen ENGEL, Rupert Timpl, Monique Aumailley, Gerd A. Kullak‐Ublick, Raúl J. Andrade, Alexander L. Gerbes, Guruprasad P. Aithal and Michael Merz. Their work appears in journals such as Molecular and Cellular Biology, Clinical and Translational Science, Drug Metabolism and Disposition, Current Biology and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.